A61K 31/365
Lactones
A61K31/365 (Lactones) appears on 4,709 US grants and 8,516 published applications in this corpus.
Search patents in A61K- Granted patents
- 4,709
- Published applications
- 8,516
- Assignees
- 3,575
- Inventors
- 14,896
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 8 | 0 |
| 1977 | 7 | 0 |
| 1978 | 3 | 0 |
| 1979 | 2 | 0 |
| 1980 | 8 | 0 |
| 1981 | 1 | 0 |
| 1982 | 4 | 0 |
| 1983 | 4 | 0 |
| 1984 | 7 | 0 |
| 1985 | 4 | 0 |
| 1986 | 11 | 0 |
| 1987 | 5 | 0 |
| 1988 | 11 | 0 |
| 1989 | 12 | 0 |
| 1990 | 17 | 0 |
| 1991 | 25 | 0 |
| 1992 | 21 | 0 |
| 1993 | 23 | 0 |
| 1994 | 42 | 0 |
| 1995 | 33 | 0 |
| 1996 | 66 | 0 |
| 1997 | 111 | 0 |
| 1998 | 76 | 0 |
| 1999 | 92 | 0 |
| 2000 | 82 | 0 |
| 2001 | 102 | 45 |
| 2002 | 105 | 207 |
| 2003 | 107 | 222 |
| 2004 | 74 | 284 |
| 2005 | 67 | 247 |
| 2006 | 71 | 293 |
| 2007 | 74 | 282 |
| 2008 | 44 | 243 |
| 2009 | 48 | 199 |
| 2010 | 95 | 288 |
| 2011 | 70 | 261 |
| 2012 | 111 | 264 |
| 2013 | 179 | 347 |
| 2014 | 193 | 375 |
| 2015 | 217 | 417 |
| 2016 | 235 | 461 |
| 2017 | 269 | 412 |
| 2018 | 230 | 353 |
| 2019 | 267 | 426 |
| 2020 | 263 | 406 |
| 2021 | 255 | 478 |
| 2022 | 228 | 469 |
| 2023 | 173 | 444 |
| 2024 | 231 | 443 |
| 2025 | 195 | 378 |
| 2026 | 131 | 272 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compositions and methods of treating lupus nephritis6 Oct 2026US 12,752,005 B2Genentech, Inc.
- Use of dextromethorphan in combination with CYP2D6 and CYP3A4 enzyme inhibitors for the treatment of pain29 Sep 2026US 12,746,235 B2Biobina LLC
- Iron supplement compositions and methods of use thereof29 Sep 2026US 12,746,257 B2ThermoLife International, LLC
- Use of atractylenolide I in preparation of medicine for preventing and/or treating cervical cancer22 Sep 2026US 12,740,967 B2Jiangsu Province Hospital of Chinese Medicine
- Nutritional formulas comprising medium chain fatty acids or esters thereof and methods related thereto15 Sep 2026US 12,734,145 B2Children's Healthcare of Atlanta, Inc.
- Interface structure for a bioelectrode8 Oct 2026US 2026/0306000 A1Teknologian tutkimuskeskus VTT Oy
- Triptolide formulations8 Oct 2026US 2026/0306412 A1Minneamrita Therapeutics LLC
- Nutritional compositions, supplements, and fortifiers8 Oct 2026US 2026/0306432 A1Societe des Produits Nestle S. A.
- Composition for use in the prevention and/or treatment of diseases mediated by tlr4, il1r, cox1/2 and/or rbp48 Oct 2026US 2026/0306445 A1
- Lipolytic and antiadipogenic coumarin derivatives8 Oct 2026US 2026/0306446 A1Karl-Franzens-Universität Graz
Most cited
By later US patents
- Sustained release systems of ascorbic acid phosphate1,391US 8,034,363 B2Advanced Technologies and Regenerative Medicine, LLC · 2011
- Spine distraction implant and method1,139US 5,836,948 ASaint Francis Medical Technologies, LLC · 1998
- Spine distraction implant and method928US 5,860,977 ASaint Francis Medical Technologies, LLC · 1999
- Spine distraction implant847US 6,048,342 ASt. Francis Medical Technologies, Inc. · 2000
- Spine distraction implant736US 6,068,630 ASt. Francis Medical Technologies, Inc. · 2000